Home > Analytics > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 544222     NSE : AKUMS    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Oct 29,2026
Price(EOD): ₹ 741.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 11,664.91 Cr
Value of ₹ 1 Lac invested in AKUMS DRUGS & PHARMACEUTICALS
on Aug 06,2024 (price: ₹ 796.35)

₹ 1 L

→

₹ 0.93 L

1W : 10.9% 1M : -7.4% 1Y : 57.1%
COMMUNITY POLL
for AKUMS DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AKUMS DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
AKUMS DRUGS & PHARMACEUTICALS 10.9% -7.4% 57.1%
SUN PHARMACEUTICAL INDUSTRIES 1.1% -4.2% 4.1%
DIVIS LABORATORIES 7.5% 1.3% 45.7%
TORRENT PHARMACEUTICALS 1.8% -6.3% 26.1%
CIPLA 1.5% -2.3% -17.3%
DR REDDYS LABORATORIES 9.3% 9.5% 4.3%
MANKIND PHARMA 11% 0.9% 1.4%
LUPIN 3.8% -3.1% 1.6%
ZYDUS LIFESCIENCES 5.2% -2.2% 16.3%

FUNDAMENTAL ANALYSIS OF AKUMS DRUGS & PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Jun2026, Y: Mar2026
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]



VALUATION OF AKUMS DRUGS & PHARMACEUTICALS

 
Valuation Score
[As on : Oct 29,2026 ]

Ratio Consolidated
P/E
P/B
P/S
39.85
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 292.69 Cr
[Latest Qtr - Jun2026 - Consolidated Results ]

3.52
P/B Calculated based on Book Value of Rs 3,313.35 Cr
[Latest Year - Mar2026 - Consolidated Results ]

2.59
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 4,501.61 Cr
[Latest Qtr - Jun2026 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 78% undervalued companies ! Discover More →

FAIR VALUE OF AKUMS DRUGS & PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
808%
1117%
35%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AKUMS DRUGS & PHARMACEUTICALS



AKUMS DRUGS & PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AKUMS DRUGS & PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2026
2025
2024
Avg_3yrs
0.01
0
1.57
0.53
0.02
0
0.69
0.24
[Last Annual Data : Mar2026]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AKUMS DRUGS & PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Sep2026

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AKUMS DRUGS & PHARMACEUTICALS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
0.76%
15.13%
14.87%
24.14%
13.93%
35.44%
45.58%
56.11%
QtrlyTrend
8
Latest Qtr: Jun2026
Quarterly Result Analysis →


AKUMS DRUGS & PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE 4.9% -3.7% 9.4%
BSE 1000 1.2% -3.2% -7.2%
NSE Indices1W1M1Y
NIFTY MIDSMALLCAP400 50:50 1.2% -5.6% NA
NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX 1.2% -4.3% -4.6%
NIFTY500 MULTICAP 50:25:25 1.2% -3.6% -5.8%
NIFTY SMALLCAP 500 1.1% -6.3% NA
NIFTY TOTAL MARKET 1.1% -3.1% -7.2%

You may also like the below Video Courses


FAQ about AKUMS DRUGS & PHARMACEUTICALS


Is AKUMS DRUGS & PHARMACEUTICALS good for long term investment?

As on Oct 29,2026, the Fundamentals of AKUMS DRUGS & PHARMACEUTICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of AKUMS DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AKUMS DRUGS & PHARMACEUTICALS UnderValued or OverValued?

As on Oct 29,2026, AKUMS DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS ?

As on Oct 29,2026, the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS is Rs. 81.65 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 81.65
Fair Value [Median EV / Sales Model] : Rs. 60.90
Fair Value [Median Price / Sales Model] : Rs. 549.57
Estimated Median Fair Value of AKUMS DRUGS & PHARMACEUTICALS : Rs. 81.65

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AKUMS DRUGS & PHARMACEUTICALS trading at a Premium or Discount?

As on Oct 29,2026, AKUMS DRUGS & PHARMACEUTICALS is trading at a Premium of 808% based on the estimates of Median Intrinsic Value!